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Abstract
Background: Membrane protein interactions play an important role in cell-to-cell recognition in various biological activities
such as in the immune or neural system. Nevertheless, there has remained the major obstacle of expression of the
membrane proteins in their active form. Recently, we and other investigators found that functional membrane proteins
express on baculovirus particles (budded virus, BV). In this study, we applied this BV display system to detect interaction
between membrane proteins important for cell-to-cell interaction in immune system.
Methodology/Principal Findings: We infected Sf9 cells with recombinant baculovirus encoding the T cell membrane
protein CD2 or its ligand CD58 and recovered the BV. We detected specific interaction between CD2-displaying BV and
CD58-displaying BV by an enzyme-linked immunosorbent assay (ELISA). Using this system, we also detected specific
interaction between two other membrane receptor-ligand pairs, CD40-CD40 ligand (CD40L), and glucocorticoid-induced
TNFR family-related protein (GITR)-GITR ligand (GITRL). Furthermore, we observed specific binding of BV displaying CD58,
CD40L, or GITRL to cells naturally expressing their respective receptors by flowcytometric analysis using anti-baculoviral
gp64 antibody. Finally we isolated CD2 cDNA from a cDNA expression library by magnetic separation using CD58-displayng
BV and anti-gp64 antibody.
Conclusions: We found the BV display system worked effectively in the detection of the interaction of membrane proteins.
Since various membrane proteins and their oligomeric complexes can be displayed on BV in the native form, this BV display
system should prove highly useful in the search for natural ligands or to develop screening systems for therapeutic
antibodies and/or compounds.
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Introduction
Cell surface proteins mediate intercellular recognition and signal
transduction. In the immune system, the interaction of an antigen-
specific T cell with an antigen presenting cell (APC) such as a B cell or
a dendritic cell (DC) is mediated by the engagement of a diversearray
of receptors on one cell, with ligands (or counter receptors) on the
opposing cell, both of which are membrane proteins [1]. Such
interactions between membrane proteins lead to various immune
responses such as cytokine secretion, antibody production or the
killing of target cells. In many cases, however, it has been difficult to
detect these receptor-ligand interactions by conventional techniques,
because the affinity of interaction between these membrane proteins
is generally low (Kd,1 mM) [2]. It is likely that oligomerization of
these proteins on the cell surface increases the avidity and stabilizes
the interaction. Sinceitis difficultto reconstitute such oligomerization
using the soluble monomeric form of these transmembrane proteins,
several different systems have been attempted. One is the fusion of
extracellular domain of membrane proteins and the Fc portion of
immunoglobulin [3,4]. Another is the engraftment of chelator-lipid
liposomes with the C-terminal hexahistidine-tagged extracellular
domain of membrane proteins [5]. However, some membrane
proteins may not retain the proper conformations required to bind
ligand (or receptor) after such manipulations.
To detect membrane protein interaction, heterotypic cell
adhesion assay has also been utilized. In this assay, two different
types of cells individually expressing receptors or ligands on their
surfaces are mixed, and heterotypic binding cells are detected
either by microscopy or by labeling with a radioisotope or
fluorochrome [6–8]. While this system allows detection of the
interaction of native transmembrane proteins and their oligomers,
endogenous receptor or other proteins may affect assays.
Meanwhile, there is accumulating evidence that heterologous
membrane proteins are displayed on the extracellular baculovirus
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investigators have reported that membrane proteins such as cell
surface receptors [10–12], a transporter [13], or enzymes [12,14]
express on BV in biologically active form. Furthermore, the co-
expression of multiple proteins results in the formation of
functional protein complex on BV, as shown by the complex
between G protein-coupled receptor and heterotrimeric G protein
subunits [11] as well as the four-protein complex of c-secretase
[14]. Since Sf9 insect cells, the host of baculovirus, are essentially
free of the homologues of mammalian immune receptors or their
ligands, this BV display system holds promise for its ability to
provide a low background environment which would enable
detection of the interaction between receptors and ligands.
In this study, we attempted to further utilize this BV display
method to develop a system for detecting interactions between
receptors and ligands, both of which are membrane proteins.
Results
Detection of receptor-ligand interaction between
membrane proteins displayed on BV
To test the application of the BV display system, we selected
three representative membrane receptor-ligand pairs (CD2-CD58
[2], CD40-CD40 ligand [15], and glucocorticoid-induced TNFR
family-related protein (GITR)-GITR ligand [16]), all of which are
important for the interaction and activation of immune cells. We
infected Sf9 cells with recombinant baculoviruses, each containing
human CD2, CD58 (CD2 ligand), mouse CD40, CD40 ligand
(CD40L), mouse GITR, or GITR ligand (GITRL) cDNA, and
recovered the BV fractions. Immunoblot analysis using antibodies
against epitope tags confirmed the expression of these membrane
proteins in the BV fractions (Fig. 1). We sought to detect receptor-
ligand interaction displayed on BV by ELISA system (illustrated in
Fig. 2A). After CD2 (receptor)-displaying BV was immobilized in
ELISA plate wells, CD58 (ligand)-displaying BV was added to the
wells. We detected the binding of CD58-BV to the wells coated
with CD2-BV by using a CD58-specific antibody (Fig. 2B left
panel). The binding of CD58-BV was dependent on CD2 because
only minimal background binding to the wells coated with wild
type BV was detected (Fig. 2B left panel). Furthermore, pre-
incubation of CD2-BV-coated wells with anti-CD2 antibody
blocked the binding of CD58-BV (Fig. 2B right panel). Similar
specific binding was observed with the opposite combination, i.e.,
plate-bound CD58-BV and CD2-BV in solution (Fig. 2C). Specific
interactions were also detected with mouse CD40 and CD40L
(Fig. 3A), and mouse GITR and GITRL (Fig. 3B). The
interactions of these proteins were blocked by respective antibodies
(data not shown).
Ligand–displaying BVs bind to receptor proteins
expressed on the cell surface
Next, we attempted to utilize the ligand protein-displaying BV
as a tool to detect receptor expression on the cell surface. To this
end, we detected the binding of BV to cells by flowcytometer using
an antibody specific to baculoviral envelope protein gp64 and a
fluorochrome-conjugated secondary antibody (illustrated in
Fig. 4A). As shown in Fig. 4B, CD58-displaying BV bound to
CD2-positive, but not CD2-negative Jurkat cells, a human T cell
leukemia cell line. We also observed the binding of mouse CD40L-
displaying BV to mouse splenic B cells, which express CD40. This
binding was blocked by an anti-mouse CD40 monoclonal
antibody (Fig. 4C). Furthermore, GITRL-displaying BV bound
to GITR-expressing T cell hybridoma 18.3.5 cells (Fig. 4D).
Application to expression cloning
Our results prompted us to explore the possibility of utilizing
BV displaying membrane proteins as the probe for expression
cloning of receptor (or ligand) cDNA. To this end, we transfected
BaF/3 cells with a human T cell cDNA library using a retroviral
transduction system. Cells bound to CD58-displaying BV were
selected with an anti-viral gp64 antibody plus secondary antibody-
coated magnetic beads. After magnetic sorting of the BV-bound
cells three times, cells expressing human CD2 were enriched
(Fig. 5A). The recovered cells were cloned by limiting dilution.
PCR of cloned BaF/3 cell genomic DNA with retroviral vector-
derived primers amplified the human CD2 cDNA sequence.
Furthermore, flowcytometric analysis confirmed that these clones
expressed human CD2 and that CD58-BV bound to these cells
(Fig. 5B).
Discussion
Functional membrane proteins such as cell surface receptors,
transporters, or enzymes, have been shown to heterologously
express on BV [9–14, reviewed in 9]. In this study, we further
applied this BV display system in an effort to detect interactions
between membrane receptors and ligands in immune cells. We
infected Sf9 cells with recombinant baculoviruses, individually
encoding CD2, CD58, CD40, CD40L, GITR or GITRL, and
recovered the BV fractions expressing these membrane proteins.
We observed specific binding of CD58 (ligand)-displaying BV to
CD2 (receptor)-displaying BV by ELISA (Fig. 2). Interactions were
also detected between CD40 and CD40L, and between GITR and
GITRL by this method (Fig. 3). We also demonstrated that
membrane protein-displaying BV can be utilized to detect cells
expressing their specific receptors (Fig. 4). Furthermore, we
successfully cloned CD2 cDNA from an expression cDNA library
by using CD58 (CD2 ligand)-displaying BV as the probe (Fig. 5).
The BV display system described here is expected to have an
advantage over other systems currently in use. It should be
applicable to various membrane receptor proteins and their
ligands (or counter receptors), which are also membrane proteins.
Since membrane proteins displayed on BV have the capacity to
move laterally on the surface of the viral membrane, they are able
to form oligomers. Currently, the fusion of the extracellular
domain of membrane proteins with the Fc portion of immuno-
globulin (Fc-fusion protein) is commonly used as a technique to
reconstitute dimer or pentamer structures and to detect receptors
(or ligands) [3,4,17]. However, it is difficult to reconstitute
Figure 1. Expression of heterologous membrane proteins in BV
fraction confirmed by Western blot. Ten micrograms of each of the
BV samples expressing CD2 or its ligand CD58 (A), CD40 or CD40L (B),
and GITR or GITRL (C) were loaded in each lane. The blotted membranes
were immuno-stained with either anti-FLAG or anti-HA antibodies
according to the attached tag as described in Materials and Methods.
The positions of the molecular mass marker proteins are indicated on
the left.
doi:10.1371/journal.pone.0004024.g001
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PLoS ONE | www.plosone.org 3 December 2008 | Volume 3 | Issue 12 | e4024Figure 3. Detection of specific interaction between CD40 and CD40L or GITR and GITRL displayed on BV. (A) Left panel: binding of
CD40L-BV to the immobilized CD40-BV. Wells were coated with 0.25 mg/well of CD40-BV or wild-type BV. Binding was detected by using a
biotinylated anti-mouse CD40L monoclonal antibody (clone MR1) and HRP-streptavidin. Right panel: binding of CD40-BV to the immobilized CD40L-
BV. Wells were coated with 1 mg/well of CD40L-BV or wild-type BV. Binding was detected by using an anti-mouse CD40 monoclonal antibody (clone
3/23) and HRP-anti rat IgG+IgM. (B) Left panel: binding of GITRL-BV to the immobilized GITR-BV. Wells were coated with 1 mg/well of GITR-BV or wild-
type BV. Binding was detected by using an anti-mouse GITRL monoclonal antibody (clone YGL386) and HRP-anti rat IgG+IgM. Right panel: binding of
GITR-BV to the immobilized GITRL-BV. Wells were coated with 1 mg/well of GITRL-BV or wild-type BV. Binding was detected by using an anti-mouse
GITR monoclonal antibody (clone DTA-1) and HRP-anti rat IgG+IgM. Filled circles indicate binding to BV displaying respective receptors (or ligands).
Open circles indicate binding to wild-type BV.
doi:10.1371/journal.pone.0004024.g003
Figure 2. Detection of specific interaction between CD2 and CD58 individually displayed on BV. (A) Schematic view of the ELISA system.
Details are described in the text. X and Y correspond to CD2 and CD58 (or vice versa for C) respectively. (B) Left panel; binding of CD58-BV to
immobilized CD2-BV (filled circles) or wild-type BV (open circles). Right panel: Blocking of CD58-BV binding to the plate-bound CD2-BV by pre-
incubation of wells with an anti-CD2 antibody (filled circles) or control mouse IgG1 (open circles). (C) Left panel: binding of CD2-BV to the
immobilized CD58-BV (filled circles) or wild-type BV (open circles). Right panel: blocking of CD2-BV binding of the plate-bound CD58-BV by pre-
incubation of wells with an anti-CD58 antibody (filled circles) or control mouse IgG2a (open circles). Each well was coated with 0.5 mg of BV. Each data
point represents detection in triplicate (error bar, 1 s.d.).
doi:10.1371/journal.pone.0004024.g002
Baculoviral Display
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more, some proteins may not retain the proper conformation after
such manipulation. Since heterologous membrane proteins express
on BV in their native forms, it is highly likely that the BV display
system reconstitutes functional hetero-oligomeric protein com-
plexes. The low background of the intrinsic expression of these
immune receptors or ligands in BV also provides a critically
important advantage.
Recently several investigators have reported that they were able
to attach retroviral or adenoviral particles to optical biosensor
surfaces and then detect interaction with antibodies or ligands
specific to the receptors displayed on the virus [18,19]. Baculoviral
Figure 4. Specific binding of ligand-displaying BV to cells expressing receptor. (A) Schematic view. X corresponds to CD2 (for B), CD40 (for
C), or GITR (for D). Y corresponds to CD58 (for B), CD40L (for C), or GITRL (for D). (B) CD58-displaying BV binds to CD2-positive (top), but not to CD2-
negative Jurkat cells (bottom). Left: binding of an anti-CD2 monoclonal antibody (clone RPA-2.10) plus a PE-anti mouse Ig-k chain antibody. Right:
binding of CD58-displaying BV plus an anti-gp64 antibody (clone A0505A) and a PE-anti mouse Ig-k chain antibody. The thin line indicates cells
incubated with the 2nd antibody only. (C) CD40-dependent binding of CD40L-displaying BV to mouse splenic B cells. BALB/c mouse splenocytes were
incubated with CD40L-displaying BV and a biotinylated anti-gp64 monoclonal antibody (clone B8147A), and then were stained with FITC-labeled
streptavidin and a PE-labeled anti-B220 antibody. CD40L-BV binding to the B cells (shown in the center lower panel) was blocked by pre-incubation
with an anti-mouse CD40 monoclonal antibody (clone HM40-3) (the right upper panel) but not by control hamster IgG (right lower panel). (D) Binding
of GITRL-displaying BV to GITR-positive cells. GITR-expressing mouse T cell hybridoma 18.3.5 cells were incubated with GITRL-displaying BV (right)o r
wild-type BV (left). Binding of BV was detected with a biotinylated anti-gp64 monoclonal antibody B8147A and PE-streptavidin. The thin line indicates
cells incubated without BV.
doi:10.1371/journal.pone.0004024.g004
Baculoviral Display
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displayed on BV retain the ability to bind their ligands (or
receptors) for at least several months at 4uC. The potential
application to the development of a biochip sensor is another
advantage of the BV display system.
In summary, we have developed a new method for detecting
membrane protein interactions using the BV display system. The
BV display system reported here is expected to be highly useful for
the analysis of cell-to-cell interaction mechanisms important in the
immune system, neural system, or developmental organ formation.
Figure 5. Expression cloning of human CD2 by using CD58-displaying BV as the probe. (A) Enrichment of human CD2-positive cells from
BaF/3 cells transfected with a human T cell cDNA library. The staining of cells with an FITC-labeled anti humanCD2 monoclonal antibody is shown.
The thin line indicates cells incubated without anti-CD2 antibody. (B) Binding of anti-human CD2 antibody and CD58-displaying BV to BaF/3 cells
isolated by magnetic sorting with CD58-BV. After the 3rd magnetic sorting and subcloning, cells were stained with an FITC-labeled anti-human CD2
monoclonal antibody and CD58-BV plus biotinylated anti-gp64 antibody and PE-streptavidin. Staining of a representative of three clones is shown.
doi:10.1371/journal.pone.0004024.g005
Baculoviral Display
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antibodies and/or compounds.
Materials and Methods
Antibodies and reagents
The horseradish peroxidase (HRP)-conjugated monoclonal
mouse anti-FLAG M2 antibody was from Sigma, and the
monoclonal mouse anti-HA antibody (F-7) was from Santa Cruz.
HRP-conjugated goat anti-mouse IgG, and anti-rat IgM+IgG
were from Jackson ImmunoResearch Laboratories and Southern
Biotechnology, respectively. Monoclonal mouse anti-human CD2
(clone RPA-2.10, unconjugated or biotinylated), anti-human
CD58 (clone 1C3 (AICD58.6)), rat anti-mouse CD40 (clone 3/
23), hamster anti-mouse CD40 (clone HM40-3), and biotinylated
hamster anti-mouse CD40L (clone MR1) antibodies were from
BD PharMingen. Unconjugated monoclonal hamster anti-mouse
CD40L (clone MR1) and FITC or PE-conjugated monoclonal rat
anti-mouse immunoglobulin k chain (clone H139.52.1) antibodies
were from Beckman Coulter. A monoclonal rat anti-mouse GITR
antibody (clone DTA-1) was generated as previously described
[20]. A monoclonal rat anti-mouse GITRL antibody (clone
YGL386) was from Serotec. Biotinylated mouse anti-human
CD58 (clone TS2/9.1.4.3) and rat anti-mouse CD40 (clone 3/
23) were from Ancell Corp. and Caltag Laboratories, respectively.
HRP-conjugated streptavidin was from Vector Laboratories.
FITC or PE-conjugated streptavidin was from BD PharMingen.
Monoclonal mouse antibodies against baculoviral envelope
protein gp64 (clones A0505A and B8147A) were established in
our laboratory.
Recombinant baculovirus construction and Sf9 cell
culture
The cDNAs for human CD2, CD58, and mouse CD40 were
amplified by PCR from human lymph node and mouse spleen
cDNA libraries (TAKARA Bio), respectively. The cDNA for
mouse CD40L was purchased from ATCC. The cDNA for mouse
GITR was amplified by RT-PCR from poly A-positive RNA
isolated from an 18.3.5 T cell hybridoma, which expresses GITR
[20]. The cDNA for mouse GITRL was cloned in our laboratory.
The FLAG tag sequence was added to the 39-terminus of CD2 and
59-terminus of CD40L and GITRL cDNAs. The sequence for the
HA tag was added to the 39-terminus of CD58, CD40, and GITR
cDNAs. The nucleotide sequences of these DNA constructs were
confirmed. The DNA fragments were subcloned into the
baculoviral transfer vector pBlueBac4.5 (Invitrogen.). Recombi-
nant baculoviruses were generated using a Bac-N-Blue system
(Invitrogen) according to the manufacturers’ instructions. Sf9 cells
were cultured as described [11].
Preparation of the budded baculovirus (BV) fractions
Sf9 cells (2610
6 cells/ml) were infected with recombinant
baculovirus at the multiplicity of infection (M.O.I.) of 5. Seventy-
two hours after infection, the BV fraction was isolated from the
culture supernatant of infected Sf9 cells as described [10,11]. The
pellets of the BV fraction were resuspended in Tris-buffered saline
(TBS) containing 1 mM EDTA, 50 mM E64, 2 mg/ml aprotinin,
and 10 mg/ml leupeptin, and stored at 4uC. The expression of
recombinant proteins in BV fraction was confirmed by SDS-
polyacrylamide gel electrophoresis and Western blot analysis using
an HRP-anti FLAG M2 antibody or an anti-HA antibody (F-7)
plus HRP-goat anti mouse IgG. Samples were not heat-treated so
as to minimize aggregation.
Enzyme-linked immunosorbent assay (ELISA)
The BV displaying human CD2 was diluted with TBS and
adsorbed to the wells of a 96-well ELISA plate (Greiner Bio-One)
overnight at 4uC. Wells were washed with phosphate-buffered
saline (PBS) and blocked with TBS containing 40% BlockAce
(Dainippon Sumitomo Pharma) for 1 h at room temperature. The
BV displaying human CD58 was diluted with Hanks’ Balanced
Salt Solution (HBSS) containing 40% BlockAce, added to the
wells, and incubated for 1 h at room temperature. Wells were
washed with PBS, and incubated with a mouse monoclonal
antibody specific to human CD58 (clone 1C3 (AICD58.6)). After
being washed with PBS containing 0.01% Tween 20, wells were
incubated with HRP-conjugated goat anti-mouse IgG, washed,
and further reacted with the tetramethylbenzidine liquid substrate
(Sigma). The reaction was terminated by the addition of 0.5 M
H2SO4, and absorbance at 450 nm was quantitated using a 96-
well plate reader. Similar assays were carried out with the
combination of human CD58-BV bound to the plate and CD2-
BV in the solution. Binding between the BVs individually
displaying mouse CD40 and CD40L, or GITR and GITRL was
also detected by using a similar ELISA method.
For the blocking experiment, CD2-BV was immobilized to the
ELISA plate and wells were blocked with BlockAce, as described
above. After pre-incubating wells with a monoclonal anti-human
CD2 antibody (clone RPA-2.10) for 15 min at room temperature,
CD58-BV was added to the wells. Wells were incubated for 1 h at
room temperature, washed, and reacted with a biotinylated anti-
CD58 antibody (clone TS2/9.1.4.3), then, with HRP-conjugated
streptavidin. Similar blocking assays were carried out with the
combination of human CD58-BV bound to the plate and the
CD2-BV in the solution using anti-human CD58 (clone 1C3
(AICD58.6)) and biotinylated anti-human CD2 (clone RPA-2.10)
for the blocking and detection antibodies, respectively. Binding
between the plate-bound mouse CD40-BV and mouse CD40L-
BV in the liquid phase was also blocked by an anti-mouse CD40
monoclonal antibody (clone HM40-3). A biotinylated anti-mouse
CD40L monoclonal antibody (clone MR1) was used as the
detection antibody. Similar blocking assays were carried out with a
combination of mouse CD40L-BV bound to the solid phase and
CD40-BV in the liquid phase by using anti-mouse CD40L (clone
MR1) and biotinylated anti-mouse CD40 (clone 3/23) for the
blocking and detection antibodies respectively.
Flowcytometric analysis
Cells were washed with FACS buffer (PBS containing 1% fetal
calf serum (FCS)) and resuspended in Dulbecco’s Modified Eagle’s
Medium (DMEM) containing 20% FCS at approximately 5610
6
cells/ml. One hundred microliters of cell suspension were
incubated with BV for 30 min at 4uC, washed twice with FACS
buffer, and incubated with an anti-baculoviral envelope protein
gp64 monoclonal antibody (clone A0505A or B8147A) for 30 min
on ice. The cells were washed, and then further incubated with
FITC or PE-labeled rat anti-mouse Ig-k monoclonal antibody for
30 min on ice. The cells were washed again, resuspended in FACS
buffer, and analyzed on a FACS Calibur flowcytometer (Becton
Dickinson).
Expression cloning
A human T lymphocyte cDNA library was constructed as
described [21] by using the pBabeX retroviral vector. Plat-E
packaging cells [22] were transfected with the cDNA library using
FuGene 6 (Roche Diagnostics). Two days later, culture superna-
tant containing retroviruses was collected and used to infect
2.4610
6 cells of mouse pro-B cell line BaF/3 (purchased from
Baculoviral Display
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After 4 h, fresh media, twice as much volume as that of the viral
stock, was added and cells were cultured overnight. On the next
day, cells were washed, resuspended in the fresh media, and
cultured overnight once again. Two days after the day of infection,
8610
7 cells were washed with DMEM containing 20% FCS and
incubated with 80 mg of hCD58-BV for 30 min at 4uC, washed
again, then incubated with 10 mg of A0505A anti-baculoviral gp64
monoclonal antibody for 20 min at 4uC. Cells were further
incubated with magnetic microbeads coated with goat anti-mouse
IgG (Miltenyl Biotech). Cells bound with hCD58-BV were isolated
by magnetic cell sorting using a MACS system (Miltenyl Biotech).
After three time purification by magnetic sorting, isolated cells
were cloned with limiting dilution. The cDNAs derived from the
retroviral library were amplified from the genomic DNA of
individual clones by PCR using upstream and downstream
retroviral vector primers (59-CAGCCCTCACTCCTTCTC-39
and 59- CCCTTTTTCTGGAGACTAAAT-39).
Acknowledgments
We thank K. Hiraishi and A. Ohnishi for technical assistance. We also
thank Dr. Kevin Boru of Pacific Edit for review of the manuscript.
Author Contributions
Conceived and designed the experiments: TS TK TK TH. Performed the
experiments: TS TS. Contributed reagents/materials/analysis tools: HI
TK SS. Wrote the paper: TS TH.
References
1. Brown MJ, Shaw S (1999) T-cell activation: Interplay at the interface. Curr Biol
9: R26–R28.
2. Davis SJ, Ikemizu S, Wild MK, Van der Merve PA (1998) CD2 and the nature
of protein interactions mediating cell-cell recognition. Immunol Rev 163:
217–236.
3. Arulanandam ARN, Moingeon P, Concino MF, Recny MA, Kato K, et al.
(1993) A soluble multimeric recombinant CD2 protein identifies CD48 as a low
affinity ligand for human CD2: Divergence of CD2 ligands during the evolution
of humans and mice. J Exp Med 177: 1439–1450.
4. Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and
expression of the Fas ligand, a novel member of the tumor necrosis factor family.
Cell 75: 1169–1178.
5. Van Broekhoven CL, Altin JG (2001) A novel system for convenient detection of
low-affinity receptor-ligand interactions: Chelator-lipid liposomes engrafted with
recombinant CD4 bind to cells expressing MHC class II. Immunol Cell Biol 79:
274–284.
6. Clayton LK, Sieh M, Pious DA, Reinherz EL (1989) Identification of human
CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 339:
548–551.
7. Arulanandam ARN, Withka JM, Wyss DF, Wagner G, Kister A, et al. (1993)
The CD58 (LFA-3) binding site is a localized and highly charged surface area on
the AGFCC9C0 face of the human CD2 adhesion domain. Proc Natl Acad Sci
USA 90: 11613–11617.
8. Liu J, Chow VTK, Jois SDS (2004) A novel, rapid and sensitive heterotypic cell
adhesion assay for CD2-CD58 interaction, and its applications for testing
inhibitory peptides. J Immunol Methods 291: 39–49.
9. Makela AR, Oker-Blom C (2008) The baculovirus display technology – an
evolving instrument for molecular screening and drug delivery. Comb Chem
High Throughput Screen 11: 86–98.
10. Loisel TP, Ansanay H, St-Onge S, Gay B, Boulanger P, et al. (1997) Recovery of
homogenous and functional b2-adrenergic receptors from extracellular baculo-
virus particles. Nature Biotechnol 15: 1300–1304.
11. Masuda K, Itoh H, Sakihama T, Akiyama C, Takahashi K, et al. (2003) A
combinatorial G protein-coupled receptor reconstitution system on budded
baculovirus. J Biol Chem 278: 24552–24562.
12. Sakihama T, Masuda K, Sato T, Doi T, Kodama T, et al. (2008) Functional
reconstitution of G-protein-coupled receptor-mediated adenylyl cyclase activa-
tion by a baculoviral co-display system. J Biotechnol 135: 28–33.
13. Saitoh R, Ohtomo T, Ito Y, Nezu J, Kimura N, et al. (2006) Recovery of
functional peptide transporter PepT1 in budded baculovirus fraction. Protein
Expr Purif 46: 130–135.
14. Hayashi I, Urano Y, Fukuda R, Isoo N, Kodama T, et al. (2004) Selective
reconstitution and recovery of functional c-secretase complex on budded
baculovirus particles. J Biol Chem 279: 38040–38046.
15. Schoenbeck U, Libby P (2001) The CD40/CD154 receptor/ligand dyad. Cell
Mol Life Sci 58: 4–43.
16. Watts TH (2005) TNF/TNFR family members in costimulation of T cell
responses. Annu Rev Immunol 23: 23–68.
17. Shiratori I, Ogasawara K, Saito T, Lanier L, Arase H (2004) Activation of
natural killer cells and dendritic cells upon recognition of a novel CD99-like
ligand by paired immunoglobulin-like type 2 receptor. J Exp Med 199: 525–533.
18. Hoffman TL, Canziani G, Jia L, Rucker J, Doms RW (2000) A biosensor assay
for studying ligand-membrane receptor interactions: Binding of antibodies and
HIV-1 Env to chemokine receptors. Proc Natl Acad Sci USA 97: 11215–11220.
19. Abad LW, Neumann M, Tobias L, Obenauer-Kutner L, Jacobs S, et al. (2002)
Development of a biosensor-based method for detection and isotyping of
antibody responses to adenoviral-based gene therapy vectors. Anal Biochem
310: 107–113.
20. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S (2002) Stimulation
of CD25
+CD4
+ regulatory T cells through GITR breaks immunological self-
tolerance. Nature Immunol 3: 135–142.
21. Kitamura T, Onishi M, Kinoshita S, Shibuya A, Miyajima A, et al. (1995)
Efficient screening of retroviral cDNA expression libraries. Proc Natl Acad Sci
USA 92: 9146–9150.
22. Morita S, Kojima T, Kitamura T (2000) Plat-E: an efficient and stable system for
transient packaging of retroviruses. Gene Ther 7: 1063–1066.
Baculoviral Display
PLoS ONE | www.plosone.org 8 December 2008 | Volume 3 | Issue 12 | e4024